NCT06597981 · RECRUITING

Dyadic Sport Stacking Program for Mild Dementia and Their Family Caregivers

This trial is testing sport stacking — a cup-stacking coordination activity — done together by a person with mild dementia and their family caregiver. The pair practices online and at home for 18 weeks. Researchers are measuring changes in cognition, mood, quality of life, and caregiver stress. This is a Phase NA (feasibility and early-stage) trial, meaning it is still building evidence for whether the approach works, not a proven therapy.

Eligibility criteria

Inclusion Criteria:
- People living with dementia (PLwD) : i) Clinical diagnosis of dementia, in accordance with the Diagnostic and Statistical Manual of Mental Disorders, fifth edition(DSM-V); ii) a minimum age of 60 years; iii) Clinical Dementia Rating (CDR) score of 1; iv) home-dwelling; v) able to communicate with the research personnel to understand training program and assessments; vi) have adequate hearing and visual function to enable skill learning; vii) informed consent.
- Family caregivers: i) aged 18 years or above; ii) living with or providing care to PLwD at least 4 hours/day; iii) able to understand and communicate in Chinese; iv) have access to smartphone/iPad/laptop and are users of one of these devices; v) consent to participate.
Exclusion Criteria:
- People living with dementia (PLwD) : i) severe mental and behavioral disorders; ii) any acute medical condition precluding participation in the program (e.g., pneumonia and cardiac insufficiency); iii) concurrent participation in other studies.
- Family caregivers: i) physically not able to participate in the sport stacking due to physical problems; ii) suffer from acute psychotic condition; iii) unable to support the PLwD in the delivery of sport stacking sessions.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-11-20

View full record on ClinicalTrials.gov

All APOE4 clinical trials